OnKure Therapeutics (OKUR)

• Market cap: $65.6M
• 1 day: -2.04%
• 5 days: -4%
• 1 month: 20.6%
• 3 months: 73.91%
• 6 months: 44.58%
• Year to date: 62.16%
• 1 year: 81.13%
• 5 years: -96.42%
• 10 years: -96.54%
• Sector: Healthcare
• Industry: Biotechnology

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Employees: 45